Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 21 for Genentech Inc.�
Company Exchange Symbol Last price Quote change Market cap
Roche Holding Ltd. VTX ROG 264.70 -2.00 (-0.75%) 182.48B
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated ...
Roche Holding Ltd. (ADR) OTCMKTS RHHBY 36.47 -0.35 (-0.96%) 251.66B
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated ...
PDL BioPharma Inc NASDAQ PDLI 9.37 -0.03 (-0.30%) 1.51B
PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of ...
Seattle Genetics, Inc. NASDAQ SGEN 35.15 -0.74 (-2.07%) 4.33B
Seattle Genetics, Inc. is biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer.
Array Biopharma Inc NASDAQ ARRY 4.09 -0.15 (-3.54%) 515.22M
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Albany Molecular Research, Inc. NASDAQ AMRI 19.13 -0.24 (-1.24%) 618.92M
Albany Molecular Research, Inc. (AMRI) is a contract research and manufacturing company. The Company provides customers with fully integrated drug discovery ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
ROCHE HLDG AG DIV RT OTCMKTS RHHVF 292.45 -0.20 (-0.07%) 205.61B
Exelixis, Inc. NASDAQ EXEL 4.12 -0.15 (-3.51%) 802.14M
Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its ...
ImmunoGen, Inc. NASDAQ IMGN 10.87 -0.24 (-2.16%) 932.79M
ImmunoGen, Inc. (ImmunoGen) develops targeted, antibody-based therapeutics for the treatment of cancer. ImmunoGen designs linkers that enable antibody-based ...
ROCHE HLDGS AG BEARE OTCMKTS RHHBF 287.50 +1.00 (0.35%) 45.84B
Roche Holding AG FRA RHO5
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated ...
ROCHE HLDG AG INH. SF 1 ETR RHO 212.10 -1.85 (-0.86%)
ROCHE HLDG AG INH. SF 1 FRA RHO 214.67 +0.23 (0.11%)
Roche Holding Ltd. (Bearer Share) SWX RO 260.00 -1.25 (-0.48%)
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated ...
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 6.96 -0.08 (-1.12%)
EXELIXIS INC. DL-,01 FRA EX9 3.12 -0.10 (-3.01%)
IMMUNOGEN INC. DL-,01 FRA IMU 8.23 +0.09 (1.16%)
ALBANY MOLECULAR DL-,01 FRA AYM 14.26 -0.31 (-2.12%)